Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Merville

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 4, 2021
IgG3 donor-specific antibodies with a proinflammatory glycosylation profile may be associated with the risk of antibody-mediated rejection after kidney transplantationVincent Pernin, Nicole Bec, Anaïs Beyze, et al.
Annals of Transplantation|April 3, 2012
Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter studyLaetitia Albano, Eric Alamartine, Olivier Toupance, et al.
BMC Nephrology|August 29, 2014
UMOD polymorphism rs12917707 is not associated with severe or stable IgA nephropathy in a large Caucasian cohortMiriana Dinic, Lidia Ghisdal, Judith Racapé, et al.
Journal of the American Society of Nephrology : JASN|May 28, 2009
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipientsChristian Noël, Daniel Abramowicz, Dominique Durand, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Identification of Predictive Markers and Outcomes of Late-onset Pneumocystis jirovecii Pneumonia in Kidney Transplant RecipientsHannah Kaminski, Julie Belliere, Laure Burguet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cellsNicolas Anfossi, Jean-Marc Doisne, Marie-Alix Peyrat, et al.
Kidney International|October 14, 2005
Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40Yahsou Delmas, Jean-François Viallard, Anne Solanilla, et al.
Transplantation|August 23, 2016
Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled TrialGeorges Mourad, Maciej Glyda, Laetitia Albano, et al.
Scientific Reports|November 9, 2022
WARS1, TYMP and GBP1 display a distinctive microcirculation pattern by immunohistochemistry during antibody-mediated rejection in kidney transplantationBertrand Chauveau, Antoine Garric, Sylvaine Di Tommaso, et al.
The Journal of Infectious Diseases|July 5, 2020
Characterization of a Unique γδ T-Cell Subset as a Specific Marker of Cytomegalovirus Infection SeverityHannah Kaminski, Coline Ménard, Bouchra El Hayani, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 4, 2021
IgG3 donor-specific antibodies with a proinflammatory glycosylation profile may be associated with the risk of antibody-mediated rejection after kidney transplantationVincent Pernin, Nicole Bec, Anaïs Beyze, et al.
Annals of Transplantation|April 3, 2012
Conversion from everolimus with low-exposure cyclosporine to everolimus with mycophenolate sodium maintenance therapy in kidney transplant recipients: a randomized, open-label multicenter studyLaetitia Albano, Eric Alamartine, Olivier Toupance, et al.
BMC Nephrology|August 29, 2014
UMOD polymorphism rs12917707 is not associated with severe or stable IgA nephropathy in a large Caucasian cohortMiriana Dinic, Lidia Ghisdal, Judith Racapé, et al.
Journal of the American Society of Nephrology : JASN|May 28, 2009
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipientsChristian Noël, Daniel Abramowicz, Dominique Durand, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Identification of Predictive Markers and Outcomes of Late-onset Pneumocystis jirovecii Pneumonia in Kidney Transplant RecipientsHannah Kaminski, Julie Belliere, Laure Burguet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cellsNicolas Anfossi, Jean-Marc Doisne, Marie-Alix Peyrat, et al.
Kidney International|October 14, 2005
Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40Yahsou Delmas, Jean-François Viallard, Anne Solanilla, et al.
Transplantation|August 23, 2016
Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled TrialGeorges Mourad, Maciej Glyda, Laetitia Albano, et al.
Scientific Reports|November 9, 2022
WARS1, TYMP and GBP1 display a distinctive microcirculation pattern by immunohistochemistry during antibody-mediated rejection in kidney transplantationBertrand Chauveau, Antoine Garric, Sylvaine Di Tommaso, et al.
The Journal of Infectious Diseases|July 5, 2020
Characterization of a Unique γδ T-Cell Subset as a Specific Marker of Cytomegalovirus Infection SeverityHannah Kaminski, Coline Ménard, Bouchra El Hayani, et al.
Pageof 13